Lipoprotein(a) and recurrent atherosclerotic cardiovascular events: the US Family Heart Database
database[Title] 2025-05-14
Summary:
CONCLUSIONS: In 273 770 individuals with ASCVD, higher lipoprotein(a) levels were associated with continuously increasing risk of recurrent ASCVD events regardless of sex and race/ethnicity that may have been partially mitigated by high impact LDL cholesterol-lowering therapy.